Michard Frederic
MiCo Sarl, Chemin de Chapallaz 4, 1135, Denens, Switzerland.
J Clin Monit Comput. 2017 Apr;31(2):253-259. doi: 10.1007/s10877-016-9925-6. Epub 2016 Aug 26.
Many mobile phone or tablet applications have been designed to control cardiovascular risk factors (obesity, smoking, sedentary lifestyle, diabetes and hypertension) or to optimize treatment adherence. Some have been shown to be useful but the long-term benefits remain to be demonstrated. Digital stethoscopes make easier the interpretation of abnormal heart sounds, and the development of pocket-sized echo machines may quickly and significantly expand the use of ultrasounds. Daily home monitoring of pulmonary artery pressures with wireless implantable sensors has been shown to be associated with a significant decrease in hospital readmissions for heart failure. There are more and more non-invasive, wireless, and wearable sensors designed to monitor heart rate, heart rate variability, respiratory rate, arterial oxygen saturation, and thoracic fluid content. They have the potential to change the way we monitor and treat patients with cardiovascular diseases in the hospital and beyond. Some may have the ability to improve quality of care, decrease the number of medical visits and hospitalization, and ultimately health care costs. Validation and outcome studies are needed to clarify, among the growing number of digital innovations and wearable sensors, which tools have real clinical value.
许多手机或平板电脑应用程序旨在控制心血管危险因素（肥胖、吸烟、久坐不动的生活方式、糖尿病和高血压）或优化治疗依从性。一些应用程序已被证明是有用的，但长期益处仍有待证实。数字听诊器使异常心音的解读更加容易，而袖珍超声心动图仪的开发可能会迅速且显著地扩大超声的使用范围。使用无线可植入传感器对肺动脉压力进行日常家庭监测已被证明与心力衰竭患者再次入院率的显著降低有关。越来越多的非侵入性、无线和可穿戴传感器被设计用于监测心率、心率变异性、呼吸频率、动脉血氧饱和度和胸腔液体含量。它们有可能改变我们在医院内外监测和治疗心血管疾病患者的方式。一些传感器可能有能力提高医疗质量，减少就诊次数和住院次数，并最终降低医疗成本。在越来越多的数字创新和可穿戴传感器中，需要进行验证和结果研究，以明确哪些工具具有真正的临床价值。
